CAPSTONE PHARMACY SERVICES INC
8-K/A, 1996-08-08
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: CAPSTONE PHARMACY SERVICES INC, 10KT405/A, 1996-08-08
Next: CAPSTONE PHARMACY SERVICES INC, 8-K/A, 1996-08-08



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549



                                   FORM 8-K/A2


                                 CURRENT REPORT



           Pursuant to Section 13 or 15(d) of the Securities Exchange
                                  Act of 1934


               Date of Report (Date of earliest event reported):
                               February 29, 1996






                        CAPSTONE PHARMACY SERVICES, INC.
             (Exact name of Registrant as specified in its charter)



<TABLE>

<S>                                  <C>                                     <C>
    Delaware                             0-20606                              11-2310352   
    --------                           -----------                            ----------   
(State or other                      (Commission File                          (Employer   
jurisdiction of                           Number)                            Identification
 incorporation)                                                                  Number)   

</TABLE>




              2930 Washington Boulevard, Baltimore, Maryland 21230
              ----------------------------------------------------
                    (Address of principal executive offices)



                                 (410) 646-7373
              ----------------------------------------------------
              (Registrant's telephone number, including area code)



                                 Not applicable
              ----------------------------------------------------
                        (Former name or former address,
                         if changed since last report)
<PAGE>   2
Item 7           Financial Statements and Exhibits

                 (b)      Pro forma financial information

                          The pro forma financial information previously filed
                        has been revised and is being filed herewith in order 
                        to replace the previous information.  The other portions
                        of the original 8-K, as amended by Form 8-K/A, have not
                        been revised and are not being re-filed with this 
                        Amendment.

<PAGE>   3
                       CAPSTONE PHARMACY SERVICES, INC.
                                      
                      PRO FORMA SELECTED FINANCIAL DATA
                                 (unaudited)

Pursuant to an Asset Purchase Agreement dated February 29, 1996 (the 
Agreement), the Registrant acquired a pharmacy business in Oak Brook, Illinois,
IMD Corporation, an Illinois corporation (IMD), for approximately $15,500,000
in cash.  The acquired business was merged into a separate surviving subsidiary
of the Registrant.  The Registrant intends to continue the acquired operations
through its subsidiary.

Also, on January 3, 1996, the Registrant closed on the acquisition of Geri-Care
Systems, Inc. and Scripts & Things, Inc., New York corporations (collectively
Geri-Care).  A Form 8-K dated December 31, 1995, and a Form 8-K/A dated
December 31, 1995, have previously been filed related to these acquisitions.

On May 22, 1995, the Registrant closed on the acquisition of PremierPharmacy,
Inc. ("Premier"), a provider of institutional and hospital pharmacy services.
The Premier acquisition was accomplished by the merger of a wholly-owned
subsidiary of the Registrant into Premier. The Registrant assumed
responsibility for the operations of Premier effective June 1, 1995, and
reported the acquisition on Form 8-K dated May 22, 1995, filed with
the Commission on June 5, 1995.

The unaudited pro forma income statement data for the ten months ended December
31, 1995 has been prepared based on historical income statements of the
Registrant, as adjusted to reflect the acquisitions of IMD, Geri-Care and
Premier as if each such agreement and merger had been effective March 1, 1995.
The pro forma income statement data may not be indicative of the future results
of operations of or what the actual results of operations would have been had
the acquisitions described above been effective March 1, 1995. The assets and
liabilities of the IMD and Geri-Care acquisitions will be included in
the Registrant's balance sheet as of March 31, 1996, to be filed on Form 10-Q.
The assets and liabilities of the Premier acquisition are included in the
Registrant's balance sheet as of December 31, 1995, filed on Form 10-K.
<PAGE>   4
                        CAPSTONE PHARMACY SERVICES, INC.
                        PRO FORMA INCOME STATEMENT DATA
                   FOR THE TEN MONTHS ENDED DECEMBER 31, 1995
                                 (in thousands)

<TABLE>
<CAPTION>
                                                Capstone Pharmacy        Premier            Premier       Geri-Care
                                                  Services, Inc.       quarter ended       Pro Forma       Systems,
                                                per Form 10-K(a)      May 31, 1995(a)     Adjustments      Inc.(c)
                                                --------------------------------------------------------------------
<S>                                                <C>                  <C>                  <C>           <C>
Net Sales                                          $ 48,841             $  5,993                           $ 5,820
Cost of Sales                                        30,876                3,877                             3,805
                                                --------------------------------------------------------------------
Gross Profit                                         17,965                2,116                             2,015
Operating Expenses:                                
    Selling and Administrative Expenses              17,869                2,842                             1,509
    Depreciation and Amortization                     1,146                  126               14 (b)           86
    Restructuring Costs                                 240                    -                                 -
                                                -------------------------------------------------------------------- 
                                              
(Loss) Income from Operations                        (1,290)                (852)                              420
                                                --------------------------------------------------------------------
                                                    
Non-Operating Expense (Income):                     
    Interest Expense, net                               634                  298                               103
    Other Income                                       (453)                  (7)                              (15)
                                                --------------------------------------------------------------------
        Total Non-Operating Expense (Income)            181                  291                                88
                                                --------------------------------------------------------------------

Income (Loss) before Income Taxes                    (1,471)              (1,143)                              332
Provision (Benefit) for Income Taxes                    178                 (227)                               25
                                                --------------------------------------------------------------------
(Loss) Income from Continuing Operations           $ (1,649)            $   (916)                          $   307
                                                ==================================================================== 
                                                 
Pro Forma Weighted Average Number of Common        
  Shares Outstanding                               
                                                   

Income (Loss) from Continuing Operations 
  Per Share                                        
</TABLE>

<TABLE>
<CAPTION>
                                                 Geri-Care                                IMD
                                                 Pro Forma            IMD               Pro Forma
                                                Adjustments       Corporation(e)       Adjustments        Pro Forma
                                                --------------------------------------------------------------------
<S>                                               <C>                <C>                 <C>             <C>
Net Sales                                                            $ 18,736            $    -          $   79,390
Cost of Sales                                                          10,603                 -              49,161
                                                --------------------------------------------------------------------
Gross Profit                                                            8,133                 -              30,229
Operating Expenses:
    Selling and Administrative Expenses                                 5,227                 -              27,447
    Depreciation and Amortization                    130 (d)              236               254 (d)           1,992
    Restructuring Costs                                                     -                 -                 240
                                                -------------------------------------------------------------------- 
                                              
(Loss) Income from Operations                       (130)               2,670              (254)                564
                                                --------------------------------------------------------------------
                                                    
Non-Operating Expense (Income):                     
    Interest Expense, net                                                 (35)              644 (f)           1,644
    Other Income                                                           (8)                -                (483)
                                                --------------------------------------------------------------------
        Total Non-Operating Expense (Income)           -                  (43)              644               1,161
                                                --------------------------------------------------------------------

Income (Loss) before Income Taxes                   (130)               2,713              (898)               (597)
Provision (Benefit) for Income Taxes                                       51                 -                  27
                                                --------------------------------------------------------------------
(Loss) Income from Continuing Operations          $ (130)             $ 2,662            $ (898)         $     (624)
                                                ==================================================================== 
                                                 
Pro Forma Weighted Average Number of Common        
  Shares Outstanding                                                                                     13,107,000
                                                                                                         ==========

Income (Loss) from Continuing Operations 
  Per Share                                                                                              $    (0.05)
                                                                                                         ==========
</TABLE>
<PAGE>   5
                        CAPSTONE PHARMACY SERVICES, INC.
                          PRO FORMA BALANCE SHEET DATA
                            AS OF DECEMBER 31, 1995
                                 (in thousands)


<TABLE>
<CAPTION>
                                                                 Geri-Care     Geri-Care                       IMD
                                            Capstone Pharmacy    Systems,      Pro Forma          IMD       Pro Forma
                                            Services, Inc.(g)    Inc. (h)     Adjustments    Corporation   Adjustments     Pro Forma
                                            ----------------------------------------------------------------------------------------
<S>                                           <C>              <C>           <C>            <C>          <C>             <C>
Current Assets:                                                      
    Cash and cash equivalents                 $   2,763        $   128                      $   296      $ 3,004 (l)      $  6,191
    Accounts Receivable, net of allowance                            
        for doubtful accounts                    12,646          2,083                        4,837            -            19,566
    Inventories                                   5,023            733                          854            -             6,610
    Other current assets                          1,518             23                            -            -             1,541
                                                ------------------------------------------------------------------------------------
        Total current assets                     21,950          2,967             -          5,987        3,004            33,908
                                                                     
Property, equipment and other assets              5,600            873        (1,949)(i)        757            -             5,281
Goodwill, net of accumulated amortization        14,581              -         6,230 (j)          -       12,191 (j)        33,002
                                                ------------------------------------------------------------------------------------
        Total Assets                          $  42,131        $ 3,840      $  4,281        $ 6,744     $ 15,195          $ 72,191
                                                ====================================================================================
                                                                     
Current Liabilities:                                                 
    Accounts payable                          $   4,671        $ 1,001                      $ 2,627     $      -          $  8,299
    Other current liabilities                     6,464          1,185                          209            -             7,858
                                                ------------------------------------------------------------------------------------
        Total current liabilities                11,135          2,186                        2,836            -            16,157
                                                ------------------------------------------------------------------------------------
                                                                     
Other long-term liabilities                       1,464              -                            -            -             1,464
Long-term debt, net of current portion            2,692            303                            -       10,303 (m)        13,298
                                                ------------------------------------------------------------------------------------
                                                  4,156            303                            -       10,303            14,762
                                                ------------------------------------------------------------------------------------
                                                                     
Stockholders' equity:                                                
    Capital                                      39,121            400         5,232 (k)          2        8,798 (n)        53,553
    Retained earnings                           (12,281)           951          (951)(k)      3,906       (3,906)(k)       (12,281)
                                                ------------------------------------------------------------------------------------
                                                 26,840          1,351         4,281          3,908        4,892            41,272
                                                ------------------------------------------------------------------------------------
                                                                     
        Total liabilities and 
          stockholders' equity                $  42,131        $ 3,840         4,281        $ 6,744     $ 15,195          $ 72,191
                                              ====================================================================================
</TABLE>
<PAGE>   6
                       CAPSTONE PHARMACY SERVICES, INC.
                                      
          NOTES TO PRO FORMA INCOME STATEMENT AND BALANCE SHEET DATA
                                      
             FOR THE TEN MONTHS ENDED AND AS OF DECEMBER 31, 1995
                                 (unaudited)


(a)      The historical financial statements of Capstone for the ten months
         ended December 31, 1995 include the results of operations of Premier
         from June 1, 1995 through December 31, 1995. The Premier column
         reflects the operations of Premier for the quarter ended May 31, 1995,
         which is the time prior to their acquisition by Capstone.

(b)      Reflects the amortization of the goodwill from the Premier acquisition
         for the quarter ended May 31, 1995.

(c)      Reflects Geri-Care results for the nine months ended September 30,
         1995, which do not differ materially from ten month results.

(d)      Reflects the amortization of goodwill from the Geri-Care and IMD
         acquisitions for the ten months ended December 31, 1995.

(e)      Reflects IMD results for the year ended December 31, 1995, which do
         not differ materially from ten month results.

(f)      Reflects additional interest expense on the long-term debt used to
         finance the IMD acquisition.

(g)      The historical balance sheet of Capstone Pharmacy Services, Inc. as of
         December 31, 1995 includes the assets and liabilities of Premier as of
         that date.

(h)      Reflects the financial position of Geri-Care as of September 30, 1995,
         which does not differ materially from its financial position at
         December 31, 1995.

(i)      Reflects post-closing entries recorded to Geri-Care's balance sheet to
         write-off computer equipment and other assets. Also reflect the
         reversal of an advance to Geri-Care's former shareholders recorded
         prior to the acquisition.

(j)      Reflects the goodwill recorded for the Geri-Care and IMD acquisitions.

(k)      Reflects the elimination of intercompany equity accounts.

(l)      Reflects the excess proceeds from the private placement that was used
         partially to finance the IMD acquisition net of cash acquired.

(m)      Reflects the long-term debt incurred to partially finance the IMD
         acquisition.

(n)      Reflects the elimination of intercompany equity accounts and a private
         placement used to partially finance the IMD acquisition.
<PAGE>   7
                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                        CAPSTONE PHARMACY SERVICES, INC.


                                        By:  /s/ Donald W. Hughes
                                             -------------------------------
                                             Vice-President and
                                             Chief Financial Officer


Date:    August 7, 1996


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission